| Primary information |
|---|
| PRRID | PRRID_0984 |
| Ligand Name | Cevarix |
| Source | GlaxoSmithKline (others) |
| Sequence of ligand | NA |
| Length | NA |
| Type | AS04 + HPV 16 & 18 L1 antigen |
| Occurence | Synthetic |
| Role of Ligand | Immunostimulant |
| Name of receptor | Toll-like receptor 4 (TLR4) |
| Type of receptor | Toll-like receptor (TLR) |
| Source | Human |
| Localization | NA |
| Domain | NA |
| Sequence of Receptor | O00206.fasta |
| Swiss prot ID | O00206 |
| Length Of Receptor | 839 |
| Function | Recognition of extracellular PAMPs
Activation leads to pro-inflammatory cytokines and type I IFNs production
Set the pace for an adaptive immune response via T and B cells. |
| Assay used | NA |
| PMID | 23017246 |
| Year of Publication | 2012 |
| Pubchem assay | Pubchem Assay |
| Primary information |
|---|
| PRRID | PRRID_0984 |
| Ligand Name | Cevarix |
| Source | GlaxoSmithKline (others) |
| Sequence of ligand | NA |
| Length | NA |
| Type | AS04 + HPV 16 & 18 L1 antigen |
| Occurence | Synthetic |
| Role of Ligand | Immunostimulant |
| Name of receptor | Toll-like receptor 4 (TLR4) |
| Type of receptor | Toll-like receptor (TLR) |
| Source | Human |
| Localization | NA |
| Domain | NA |
| Sequence of Receptor | O00206.fasta |
| Swiss prot ID | O00206 |
| Length Of Receptor | 839 |
| Function | Recognition of extracellular PAMPs
Activation leads to pro-inflammatory cytokines and type I IFNs production
Set the pace for an adaptive immune response via T and B cells. |
| Assay used | NA |
| PMID | 23017246 |
| Year of Publication | 2012 |
| Pubchem assay | Pubchem Assay |